The block to membrane fusion differs with the site of ligand insertion in modified retroviral envelope proteins

Journal of General Virology

Volumn 89, Issue 4, 2008, Pages 1049-1058

  Ryu, Byoung Y ^a,b   Zavorotinskaya, Tatiana ^a,c   Trentin, Bernadette ^a,d   Albritton, Lorraine M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d Laboratoire de Biochimie Genetique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; LIGAND; MEMBRANE LIPID; PROLINE; RETROVIRUS VECTOR; VIRUS ENVELOPE PROTEIN; INTERLEUKIN 13 RECEPTOR ALPHA2;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GENE INSERTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LIPID MEMBRANE; MEMBRANE FUSION; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; VIRUS INFECTION; ANIMAL; CELL LINE; GENE VECTOR; GENETICS; METABOLISM; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE;

AMPHOTROPIC MURINE LEUKEMIA VIRUS;

ANIMALS; CELL LINE; GENETIC VECTORS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; LIGANDS; MEMBRANE FUSION; MICE; MOLONEY MURINE LEUKEMIA VIRUS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

EID: 45549098499     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83445-0     Document Type: Article

References (42)

1. Bae, Y., Kingsman, S. M. & Kingsman, A. J. (1997). Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J Virol 71, 2092-2099.
2. Battini, J.-L., Danos, O. & Heard, J. M. (1995). Receptor-binding domain of murine leukemia virus envelope glycoproteins. J Virol 69, 713-719.
3. Benedict C. A., Tun, R. Y., Rubinstein, D. B., Guillaume, T., Cannon, P. M. & Anderson, W. F. (1999). Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion. Hum Gene Ther 10, 545-557.
4. Bernard, J., Treton, D., Vermot-Desroches, C., Boden, C., Horellou, P., Angevin, E., Galanaud, P., Wijdenes, J. & Richard, Y. (2001). Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for 1L13. Lab Invest 81, 1223-1231.
5. Blumenthal, R., Sarkar, D. P., Durell, S., Howard, D. E. & Morris, S. J. (1996). Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J Cell Biol 135, 63-71.
6. Chernomordik, L. V., Frolov, V. A., Leikina, E., Bronk, P. & Zimmerberg, J. (1998). The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hernifusion, and lipidic fusion pore formation. J Cell Biol 140, 1369-1382.
7. Cosset F. L., Morling, F. J., Takeuchi, Y, Weiss, R. A., Collins, M. K. L & Russell, S. J. (1995). Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 69, 6314-6322.
8. Danieli, T., Pelletier, S. L., Henis, Y. I. & White, J. M. (1996). Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J Cell Biol 133, 559-569.
9. Debinski, W., Gibo, D. M., Slagle, B., Powers, S. K. & Gillespie, G. Y. (1999). Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with ghoblastoma multiforme. Int J Oncol 15, 481-486.
10. Dumonceaux, J., Nisole, S., Chanel, C., Quivet, L., Amara, A., Baleux, F., Briand, P. & Hazan, U. (1998). Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol 72, 512-519.
11. Edinger, A. L., Mankowski, J. L., Doranz, B. J., Margulies, B. J., Lee, B., Rucker, J., Sharron, M., Hoffman, T. L., Berson, J. F. & other authors (1997). CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci U S A 94, 14742-14747.
12. Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M, Turner, J. D., McKnight A., Thomas, J. F., Stoebenau-Haggarty, B., Choe, S. & other authors (1996). CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745-756.
13. Gollan, T. J. & Green, M. R. (2002). Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope. J Virol 76, 3558-3563.
14. Hall, F. L., Gordon, E. M., Wu, L., Zhu, N. L., Skotzko, M. J., Starnes, V. A. & Anderson, W. F. (1997). Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein. Hum Gene Ther 8, 2183-2192.
15. Hunter, E. (1997). Viral entry and receptors. In Retroviruses, pp. 71-120. Edited by J. M. Coffin, S. H. Hughes & H. E. Varmus. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
16. Kasahara, N., Dozy, A. M. & Kan, Y. W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373-1376.
17. Katane, M., Takao, E., Kubo, Y., Fujita, R. & Amanuma, H. (2002). Factors affecting the direct targeting of murine leukemia virus vectors containing peptide ligands in the envelope protein. EMBO Pep 3, 899-904.
18. Kizhatil, K., Gromley, A. & Albritton, L. M. (2001). Two point mutations produce infectious retrovirus bearing a green fluorescent protein-SU fusion protein. J Virol 75, 11881-11885.
19. Lavillette, D., Russell, S. J. & Cosset F. L. (2001). Retargeting gene delivery using surface-engineered retroviral vector particles. Curr Opin Biotechnol 12, 461-466.
20. Lavillette, D., Marin, M., Ruggieri, A., Mallet F., Cosset, F. L. & Kabat, D. (2002). The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/ cell surface receptors. J Virol 76, 6442-6452.
21. Lorimer, I. A. & Lavictoire, S. J. (2000). Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe. J Immunol Methods 237, 147-157.
22. Melikyan, G. B., White, J. M. & Cohen, F. S. (1995). GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J Cell Biol 131, 679-691.
23. Melikyan, G. B., Brener, S. A., Ok, D. C. & Cohen, F. S. (1997). Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol 136, 995-1005.
24. Melikyan, G. B., Markosyan, R. M., Brener, S. A., Rozenberg, Y. & Cohen, F. S. (2000a). Role of the cytoplasmic tail of ecotropic Moloney murine leukemia virus Env protein in fusion pore formation. J Virol 74, 447-455.
25. Melikyan, G. B., Markosyan, R. M., Hemmati, H., Delmedico, M. K., Lambert, D. M. & Cohen, F. S. (2000b). Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not [lie bundle configuration, induces membrane fusion. J Cell Biol 151, 413-423.
26. Munoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E. & Blumenthal, R. (1998). Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J Cell Biol 140, 315-323.
27. O'Doherty, U., Swiggard, W. J. & Malim, M. H. (2000). Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74, 10074-10080.
28. Pinter, A., Kopelman, R., Li, Z., Kayman, S. C. & Sanders, D. A. (1997). Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes. J Virol 71, 8073-8077.
29. Pizzato, M., Marlow, S. A., Blair, E. D. & Takeuchi, Y. (1999). Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J Virol 73, 8599-8611.
30. Rein, A., Mirro, J., Haynes, J. G., Ernst S. M. & Nagashima, K. (1994). Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol 68, 1773-1781.
31. Russell, S. J. & Cosset, F. L. (1999). Modifying the host range properties of retroviral vectors. J Gene Med 1, 300-311.
32. Smith, J. G., Mothes, W., Blacklow, S. C. & Cunningham, J. M. (2004). The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infection. J Virol 78, 1403-1410.
33. Somia, N. V., Zoppe, M. & Verma, I. M. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci U S A 92, 7570-7574.
34. Sommerfelt, M. A. (1999). Retrovirus receptors. J Gen Virol 80, 3049-3064.
35. Taylor, G. M., Zullo, A. J., Larson, G. M. & Sanders, D. A. (2003). Promotion of retroviral entry in the absence of envelope protein by chlorpromazine. Virology 316, 184-189.
36. Valsesia-Wittmann, S., Morling, F. J., Nilson, B. H., Takeuchi, Y., Russell, S. J. & Cosset, F. L. (1996). Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N-terminus of Moloney murine leukemia virus SU. J Virol 70, 2059-2064.
37. Waehler, R., Russell, S. J. & Curiel, D. T. (2007). Engineering targeted viral vectors for gene therapy. Nat Rev Genet 8, 573-587.
38. Weimin Wu, B., Cannon, P. M., Gordon, E. M., Hall, F. L. & Anderson, W. F. (1998). Characterization of the proline-rich region of murine leukemia virus envelope protein. J Virol 72, 5383-5391.
39. Zavorotinskaya, T. & Albritton, L. M. (1999). Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein. J Virol 73, 5034-5042.
40. Zavorotinskaya, T. & Albritton, L. M. (2001). Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein. Mol Ther 3, 323-328.
41. ZavorotinskLya, T., Qian, Z., Franks, J. & Albritton, L. M. (2004). A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J Virol 78, 473-481.
42. Zhao, Y., Zhu, L., Lee, S., Li, L, Chang, E., Soong, N. W., Douer, D. & Anderson, W. F. (1999). Identification of the block in targeted retroviral-mediated gene transfer. Proc Natl Acad Sci U S A 96, 4005-4010.